| Literature DB >> 30070631 |
Giulia Bertolin1,2, Anne-Laure Bulteau3,4,5, Marie-Clotilde Alves-Guerra6,7,8, Agnes Burel9, Marie-Thérèse Lavault9, Olivia Gavard1,2,10,11, Stephanie Le Bras1,2, Jean-Philippe Gagné11, Guy G Poirier11, Roland Le Borgne1,2,10, Claude Prigent1,2,10, Marc Tramier1,2,9.
Abstract
Many epithelial cancers show cell cycle dysfunction tightly correlated with the overexpression of the serine/threonine kinase Aurora A (AURKA). Its role in mitotic progression has been extensively characterised, and evidence for new AURKA functions emerges. Here, we reveal that AURKA is located and imported in mitochondria in several human cancer cell lines. Mitochondrial AURKA impacts on two organelle functions: mitochondrial dynamics and energy production. When AURKA is expressed at endogenous levels during interphase, it induces mitochondrial fragmentation independently from RALA. Conversely, AURKA enhances mitochondrial fusion and ATP production when it is over-expressed. We demonstrate that AURKA directly regulates mitochondrial functions and that AURKA over-expression promotes metabolic reprogramming by increasing mitochondrial interconnectivity. Our work paves the way to anti-cancer therapeutics based on the simultaneous targeting of mitochondrial functions and AURKA inhibition.Entities:
Keywords: D. melanogaster; cancer biology; cell biology; cell cycle; epithelial cancer; human; mitochondria
Mesh:
Substances:
Year: 2018 PMID: 30070631 PMCID: PMC6140714 DOI: 10.7554/eLife.38111
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140